← All organizations

Glycotope GmbH

For profit

Also known as: Glycotope Biotechnology GmbH | Glycotope GmbH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 2, 2017

Acquired by Octapharma on Oct 8, 2015

Timeline

2000s

Jun 1, 2001
Glycotope GmbH— Founded

2010s

Oct 8, 2015
Octapharma— Acquired By

Drugs by trial phase (8 distinct, 9 trials)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (18)

NCT03360734Lead sponsorPhase 1Nov 2, 2017
NCT02052960Lead sponsorPhase 2Jan 1, 2014
NCT01899599Lead sponsorPhase 2Sep 1, 2013
NCT01794208Lead sponsorPhase 2Jan 1, 2013
NCT01794208Study directorPhase 2Jan 1, 2013
NCT01477073Study directorPhase 1Oct 1, 2011
NCT01477073Lead sponsorPhase 1Oct 1, 2011
NCT01477073CollaboratorPhase 1Oct 1, 2011
NCT01409343Lead sponsorPhase 1Jul 1, 2011
NCT01409343Study directorPhase 1Jul 1, 2011
NCT01409343CollaboratorPhase 1Jul 1, 2011
NCT01354886CollaboratorPhase 1Apr 1, 2011
NCT01354886Lead sponsorPhase 1Apr 1, 2011
NCT01354886Study directorPhase 1Apr 1, 2011
NCT01222637Study directorPhase 1Aug 1, 2010

Details

Founded: Heidelberg, DE Jun 1, 2001
Last known activity: Nov 2, 2017